ATE311449T1 - Stabil transfizierte zelllinien welche gaba-a- rezeptoren mit der untereinheitenzusammensetzung alpha-3, beta-3 und gamma-2 exprimieren - Google Patents

Stabil transfizierte zelllinien welche gaba-a- rezeptoren mit der untereinheitenzusammensetzung alpha-3, beta-3 und gamma-2 exprimieren

Info

Publication number
ATE311449T1
ATE311449T1 AT97203995T AT97203995T ATE311449T1 AT E311449 T1 ATE311449 T1 AT E311449T1 AT 97203995 T AT97203995 T AT 97203995T AT 97203995 T AT97203995 T AT 97203995T AT E311449 T1 ATE311449 T1 AT E311449T1
Authority
AT
Austria
Prior art keywords
sub
receptors
gamma
beta
cell lines
Prior art date
Application number
AT97203995T
Other languages
English (en)
Inventor
Karen L Hadingham
Paul J Whiting
Original Assignee
Merck Sharp & Dohme
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929225776A external-priority patent/GB9225776D0/en
Priority claimed from GB939318528A external-priority patent/GB9318528D0/en
Application filed by Merck Sharp & Dohme filed Critical Merck Sharp & Dohme
Application granted granted Critical
Publication of ATE311449T1 publication Critical patent/ATE311449T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70571—Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Neurology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT97203995T 1992-12-10 1993-12-07 Stabil transfizierte zelllinien welche gaba-a- rezeptoren mit der untereinheitenzusammensetzung alpha-3, beta-3 und gamma-2 exprimieren ATE311449T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929225776A GB9225776D0 (en) 1992-12-10 1992-12-10 Cell line
GB939318528A GB9318528D0 (en) 1993-09-07 1993-09-07 Cell line

Publications (1)

Publication Number Publication Date
ATE311449T1 true ATE311449T1 (de) 2005-12-15

Family

ID=26302133

Family Applications (2)

Application Number Title Priority Date Filing Date
AT94902039T ATE170921T1 (de) 1992-12-10 1993-12-07 Stabil transfizierte zelllinien welche gaba-a rezeptoren exprimieren
AT97203995T ATE311449T1 (de) 1992-12-10 1993-12-07 Stabil transfizierte zelllinien welche gaba-a- rezeptoren mit der untereinheitenzusammensetzung alpha-3, beta-3 und gamma-2 exprimieren

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT94902039T ATE170921T1 (de) 1992-12-10 1993-12-07 Stabil transfizierte zelllinien welche gaba-a rezeptoren exprimieren

Country Status (9)

Country Link
US (1) US5652100A (de)
EP (3) EP0673419B1 (de)
JP (1) JP3464672B2 (de)
AT (2) ATE170921T1 (de)
AU (1) AU680852B2 (de)
DE (3) DE69334187T2 (de)
DK (1) DK0856581T3 (de)
ES (2) ES2296064T3 (de)
WO (1) WO1994013799A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9420010D0 (en) 1994-10-01 1994-11-16 Marck Sharp & Dohme Limited Nucleic acids
GB9503601D0 (en) * 1995-02-23 1995-04-12 Merck Sharp & Dohme Method of treatment and method of manufacture of medicament
WO1997017369A2 (en) * 1995-11-09 1997-05-15 Trustees Of Boston University Dna comprising a neuron-specific transcriptional promoter and its use in a gene therapy vector
JP3868502B2 (ja) * 1996-10-25 2007-01-17 ニューロサーチ・アクティーゼルスカブ 抗不安作用を有する化合物の同定方法
EP0948617A1 (de) * 1996-11-25 1999-10-13 Merck Sharp & Dohme Ltd. KLONIERTE cDNA-SEQUENZ EINER NEUEN GABA-REZEPTOR-UNTEREINHEIT UND STABIL KOTRANSFIZIERTE ZELLLINIEN
GB9708479D0 (en) 1997-04-25 1997-06-18 Merck Sharp & Dohme Nucleic acids
US7029870B1 (en) 1997-07-03 2006-04-18 Human Genome Sciences, Inc. Gabaa receptor epsilon subunits
GB9715164D0 (en) * 1997-07-19 1997-09-24 Medical Res Council Improvements in or relating to expression of nucleic acid sequences in cerebellar cells
US6762294B2 (en) 1999-02-19 2004-07-13 The United States Of America As Represented By The Department Of Health And Human Services Polynucleotides encoding polymorphic human GABAA receptor α-6 subunit
EP1153130B1 (de) * 1999-02-19 2005-11-23 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Polymorphismus im gen für die menschliche gaba a rezeptor alpha 6 untereinheit
WO2002029418A1 (en) * 2000-10-05 2002-04-11 Hanns Mohler Selective anxiolytic therapeutic agents
US7282344B2 (en) * 2001-06-06 2007-10-16 Neurosearch A/S Cation conducting GABAA receptors and their use
US20070112017A1 (en) * 2005-10-31 2007-05-17 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
EP3009513A1 (de) * 2008-02-01 2016-04-20 Chromocell Corporation Neuartige zelllinien und verfahren
US20150374705A1 (en) 2012-02-14 2015-12-31 Shanghai Institues for Biological Sciences Substances for treatment or relief of pain
CN106854207B (zh) 2015-12-08 2019-10-29 上海赛默罗生物科技有限公司 呔嗪类衍生物、其制备方法、药物组合物和用途
CN110256440B (zh) 2018-03-12 2023-05-23 上海赛默罗生物科技有限公司 酞嗪异噁唑烷氧基衍生物、其制备方法、药物组合物和用途
CN112979655A (zh) 2019-12-16 2021-06-18 上海赛默罗生物科技有限公司 三唑并哒嗪类衍生物、其制备方法、药物组合物和用途
WO2023016521A1 (zh) 2021-08-12 2023-02-16 上海赛默罗生物科技有限公司 取代三唑类衍生物、其制备方法、药物组合物和用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9112504D0 (en) * 1991-06-11 1991-07-31 Merck Sharp & Dohme Cell line
US5166066A (en) * 1991-07-11 1992-11-24 The Upjohn Company Transformed cells comprising GABAA receptors

Also Published As

Publication number Publication date
ES2296064T3 (es) 2008-04-16
EP0673419B1 (de) 1998-09-09
DE69320985D1 (de) 1998-10-15
AU5655494A (en) 1994-07-04
EP0856581B1 (de) 2005-11-30
WO1994013799A1 (en) 1994-06-23
DE69333923T2 (de) 2006-08-03
EP0856581A3 (de) 1999-11-24
DE69320985T2 (de) 1999-05-12
EP0856581A2 (de) 1998-08-05
DE69334187D1 (de) 2008-01-03
DE69334187T2 (de) 2008-10-09
ATE170921T1 (de) 1998-09-15
JP3464672B2 (ja) 2003-11-10
AU680852B2 (en) 1997-08-14
EP1605046B1 (de) 2007-11-21
JPH08504330A (ja) 1996-05-14
EP1605046A1 (de) 2005-12-14
DK0856581T3 (da) 2006-03-27
ES2251011T3 (es) 2006-04-16
EP0673419A1 (de) 1995-09-27
US5652100A (en) 1997-07-29
DE69333923D1 (de) 2006-01-05

Similar Documents

Publication Publication Date Title
ATE311449T1 (de) Stabil transfizierte zelllinien welche gaba-a- rezeptoren mit der untereinheitenzusammensetzung alpha-3, beta-3 und gamma-2 exprimieren
ES2300276T3 (es) P40 de interleuquina-12 de mamifero e interleuquina b30. sus combinaciones. anticuerpos. usos en composiciones farmaceuticas.
MX9707021A (es) Receptor de il-7.
BR9908219A (pt) Pró-perfumes cìclos tendo taxas de liberação de matéria-prima de álcool com fragrância modificável
HK1002827A1 (en) Moisturizing lipstick compositions
HUP9900605A3 (en) Lipopolyamines as transfection agents, preparation and use thereof and pharmaceutical compositions containing them
AP2001002054A0 (en) Use of biogenic estrogen sulfamates for hormone replacement therapy.
BR9406025A (pt) Composição para barbear não de aerossol
EP0233009A3 (en) System for delivering drug with enhanced bioacceptability
EP1258530A3 (de) Gaba-a Rezeptoruntereinheiten (alpha-2, alpha-3, alpha-5, alpha-6, beta-2) und transfektierte Zellen, die diese expremieren
DK0667768T3 (da) Anvendelse af toremifen til behandling af SLE
EP0736600A3 (de) Verwendung von einem Immunschwäche unterdrückenden Virus welcher Lymphokine unterdrückt (ISL) zur Verhinderung der viralen Replikaten insbesondere der von Retroviren
BR9815335A (pt) Uso de antagonistas de receptor de endotelina.
CA2148599A1 (en) Cdnas encoding human nmda-22a receptor subunit and isoforms of the human nmda-r1 receptor subunit, transfected cell line expressing them
WO1998038968A3 (de) Kosmetisches körperpflegepräparat das honig enthält und verfahren zu seiner herstellung
IL86077A0 (en) Receptor of the small rhinovirus receptor group,its preparation and pharmaceutical compositions containing it
DE3560313D1 (en) Improvements in or relating to anticonvulsant agents
HUP9600517A2 (en) New tricyclic derivatives, their preparation, their use for the preparation of optically active or valemic colchicine and thiocolchine and analogues and derivatives and intermediates
CA2151236A1 (en) Stably transfected cell lines expressing gaba-a receptors
HUP9903619A2 (hu) 5HT2c Antagonistát és D2 antagonistát tartalmazó gyógyszerkészítmény
HUP0004362A2 (hu) Karbamazepint vagy származékait tartalmazó parenterális készítmények
NZ217356A (en) Benzamide derivatives and pharmaceutical compositions
ATE252636T1 (de) Klonierung und expression von dem beta app-c100 rezeptor
GB9708479D0 (en) Nucleic acids
FR2725900B1 (fr) Utilisation d'antagonistes des recepteurs nk1 pour la preparation de medicaments a action cardioregulatrice

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties